Accelerate From Discovery to Market — With AI.
Zabrizon's AI platform helps pharmaceutical, biotech, and medical device companies compress development timelines, reduce trial costs, automate regulatory workflows, and strengthen pharmacovigilance — at every stage of the product lifecycle.
AI Across Every Stage of Drug Development
From target identification to post-market surveillance, Zabrizon provides specialised AI capabilities tailored to each phase of the pharmaceutical value chain.
Drug Discovery AI
AI-powered target identification, molecular property prediction, and compound screening to compress the discovery timeline.
- Generative AI for novel molecule design
- Multi-omics data integration and analysis
- Biomarker identification and patient stratification
- In-silico ADMET prediction
Clinical Trial Management
End-to-end AI platform for protocol design, site selection, patient recruitment, and real-time trial monitoring.
- AI-powered protocol feasibility and design optimisation
- Predictive site performance and enrolment forecasting
- Electronic data capture with automated medical coding
- Safety signal detection and real-time monitoring
Regulatory Compliance Automation
AI that reads, interprets, and applies evolving regulatory requirements across FDA, EMA, and ICH guidelines.
- Automated regulatory intelligence and change tracking
- AI-assisted submission document generation
- Gap analysis against current CMC requirements
- Regulatory pathway strategy modelling
Pharmacovigilance
Continuous adverse event detection, signal assessment, and PSUR automation to protect patients and maintain market authorisation.
- Automated ICSR processing from all data sources
- Medical literature monitoring and signal detection
- Risk management system documentation
- Aggregate report generation (PSUR / PBRER)
Medical Affairs Automation
AI that supports medical writing, scientific exchange, and KOL engagement at scale.
- AI-assisted medical writing and content generation
- KOL mapping, profiling, and engagement tracking
- RWE generation and outcomes research support
- Formulary submission and health economics modelling
Supply Chain Optimisation
Demand forecasting, cold chain monitoring, and distribution optimisation to ensure drug availability.
- Predictive demand planning for specialty and biologics
- Cold chain IoT monitoring and deviation alerts
- Serialisation and track-and-trace compliance
- Shortage prediction and inventory optimisation
AI-Augmented Drug Development Pipeline
Zabrizon embeds AI at every checkpoint of the development process, compressing timelines and reducing costly late-stage failures.
Discovery
Target identification, compound screening, and hit-to-lead with generative AI
Preclinical
ADMET prediction, biomarker discovery, and toxicology modelling
Phase I–III
AI-powered trial design, site selection, enrolment, and safety monitoring
Regulatory
Automated submission generation, gap analysis, and response management
Post-Market
Pharmacovigilance, RWE generation, and lifecycle management
Built for Life Sciences Regulatory Standards
Zabrizon's platform is validated against the most demanding regulatory frameworks in pharmaceutical development.
Accelerate Your Pipeline with Purpose-Built Life Sciences AI.
Talk to a life sciences AI specialist and explore how Zabrizon can compress your development timeline.
Explore All Life Sciences Solutions